Yuan, J., Yin, X., Tang, B., Ma, H., Zhang, L., Li, L., . . . Ren, Z. (2019). Transarterial Chemoembolization (TACE) Combined with Sorafenib in Treatment of HBV Background Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: A Propensity Score Matching Study. Biomed Res Int.
Stile di citazione ChicagoYuan, Jia, Xin Yin, Bei Tang, Hui Ma, Lan Zhang, Lixin Li, Rongxin Chen, Xiaoying Xie, e Zhenggang Ren. "Transarterial Chemoembolization (TACE) Combined With Sorafenib in Treatment of HBV Background Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Propensity Score Matching Study." Biomed Res Int 2019.
Citazione MLAYuan, Jia, et al. "Transarterial Chemoembolization (TACE) Combined With Sorafenib in Treatment of HBV Background Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Propensity Score Matching Study." Biomed Res Int 2019.